Skip to main content
. 2015 Jul 3;6(30):30317–30326. doi: 10.18632/oncotarget.4505

Figure 2. Subgroup survival analysis according to treatment response.

Figure 2

In patients who got CR after treatment, positive post-treatment EBV-DNA level correlated with significantly inferior PFS and OS A, C. In patients who did not get CR after treatment, positive post-treatment EBV-DNA level correlated with significantly inferior PFS but not OS B, D.